Cynosure Group’s Vanguard FTSE Emerging Markets ETF VWO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$336K Hold
6,217
0.04% 177
2025
Q4
$334K Hold
6,217
0.03% 388
2025
Q3
$337K Hold
6,217
0.04% 327
2025
Q2
$307K Sell
6,217
-6,638
-52% -$308K 0.03% 366
2025
Q1
$582K Buy
12,855
+476
+4% +$21.4K 0.08% 136
2024
Q4
$545K Hold
12,379
0.08% 134
2024
Q3
$592K Sell
12,379
-2,230
-15% -$99.3K 0.09% 136
2024
Q2
$639K Sell
14,609
-2,874
-16% -$124K 0.1% 136
2024
Q1
$730K Buy
17,483
+4,277
+32% +$175K 0.13% 84
2023
Q4
$542K Buy
13,206
+1,620
+14% +$64.3K 0.1% 119
2023
Q3
$454K Buy
+11,586
New +$473K 0.14% 112
2020
Q1
Sell
-243,387
Closed -$10.8M 78
2019
Q4
$10.8M Hold
243,387
5.77% 6
2019
Q3
$9.8M Hold
243,387
5.33% 6
2019
Q2
$10.4M Hold
243,387
4.75% 6
2019
Q1
$10.3M Hold
243,387
6.41% 6
2018
Q4
$9.27M Buy
+243,387
New +$9.43M 5.47% 6

Other funds holding VWO

Cynosure Group's VWO Position: Q1 2026 in Review

Cynosure Group held its Vanguard FTSE Emerging Markets ETF (VWO) position steady in Q1 2026 at 6,217 shares worth $336K. The position accounts for 0.04% of the portfolio, ranked #177.

Cynosure Group first reported a position in VWO in Q4 2018 and has held it in 16 quarters since. The position peaked at $10.8M in Q4 2019. 2,537 funds tracked by Wall St. Rank hold VWO as of Q1 2026.

  • Cynosure Group held 6,217 shares of Vanguard FTSE Emerging Markets ETF worth $336K as of Q1 2026.
  • Cynosure Group left its Vanguard FTSE Emerging Markets ETF share count unchanged in Q1 2026.
  • Vanguard FTSE Emerging Markets ETF made up 0.04% of Cynosure Group's portfolio in Q1 2026, its #177 holding.
  • Cynosure Group first reported a position in Vanguard FTSE Emerging Markets ETF in Q4 2018 and has held it in 16 quarters since.
  • Cynosure Group's Vanguard FTSE Emerging Markets ETF position peaked at $10.8M in Q4 2019.
  • 2,537 funds tracked by Wall St. Rank held Vanguard FTSE Emerging Markets ETF as of Q1 2026.

Based on Cynosure Group's 13F filing for Q1 2026, filed 14 May 2026.